Literature DB >> 24906689

Animal models of inflammatory bowel disease: a review.

Nidhi Goyal1, Ajay Rana, Abhilasha Ahlawat, Krishna Reddy V Bijjem, Puneet Kumar.   

Abstract

Inflammatory bowel disease (IBD) represents a group of idiopathic chronic inflammatory intestinal conditions associated with various areas of the GI tract, including two types of inflammatory conditions, i.e., ulcerative colitis (UC) and Crohn's disease (CD). Both UC and CD are chronic inflammatory disorders of the intestine; in UC, inflammation starts in the rectum and generally extends proximally in a continuous manner through the entire colon. Bloody diarrhea, presence of blood and mucus mixed with stool, accompanied by lower abdominal cramping, are the characteristic symptoms of the disease. While in CD, inflammatory condition may affect any part of the GI tract from mouth to anus. It mainly causes abdominal pain, diarrhea, vomiting and weight loss. Although the basic etiology of IBD is unknown, there are several factors that may contribute to the pathogenesis of this disease, such as dysregulation of immune system or commensal bacteria, oxidative stress and inflammatory mediators. In order to understand these different etiological factors, a number of experimental models are available in the scientific research, including chemical-induced, spontaneous, genetically engineered and transgenic models. These models represent a major source of information about biological systems and are clinically relevant to the human IBD. Since there is less collective data available in one single article discussing about all these models, in this review an effort is made to study the outline of pathophysiology and various types of animal models used in the research study of IBD and other disease-related complications.

Entities:  

Mesh:

Year:  2014        PMID: 24906689     DOI: 10.1007/s10787-014-0207-y

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  112 in total

1.  An α-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-κB in rats with TNBS-induced colitis.

Authors:  Aktham Hassan; Ayman Ibrahim; Khaly Mbodji; Moïse Coëffier; Frédéric Ziegler; Frédéric Bounoure; Jean-Michel Chardigny; Mohamed Skiba; Guillaume Savoye; Pierre Déchelotte; Rachel Marion-Letellier
Journal:  J Nutr       Date:  2010-08-19       Impact factor: 4.798

2.  Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.

Authors:  Joshua-Ka-Shun Ko; Flora-Ying-Lee Lam; Andrew-Pok-Lap Cheung
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

3.  Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.

Authors:  Johan Burisch
Journal:  Dan Med J       Date:  2014-01       Impact factor: 1.240

Review 4.  Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease.

Authors:  S Wirtz; M F Neurath
Journal:  Int J Colorectal Dis       Date:  2000-06       Impact factor: 2.571

5.  Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients.

Authors:  D W Owens; N J Wilson; A J M Hill; E L Rugg; R M Porter; A M Hutcheson; R A Quinlan; D van Heel; M Parkes; D P Jewell; S S Campbell; S Ghosh; J Satsangi; E B Lane
Journal:  J Cell Sci       Date:  2004-04-15       Impact factor: 5.285

6.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

7.  Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells.

Authors:  Emiko Mizoguchi
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

8.  Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation.

Authors:  Olga Gutierrez; Carlos Pipaon; Naohiro Inohara; Ana Fontalba; Yasunori Ogura; Felipe Prosper; Gabriel Nunez; Jose L Fernandez-Luna
Journal:  J Biol Chem       Date:  2002-08-22       Impact factor: 5.157

9.  Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice.

Authors:  H Baribault; J Penner; R V Iozzo; M Wilson-Heiner
Journal:  Genes Dev       Date:  1994-12-15       Impact factor: 11.361

10.  Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa.

Authors:  M Watanabe; Y Ueno; T Yajima; S Okamoto; T Hayashi; M Yamazaki; Y Iwao; H Ishii; S Habu; M Uehira; H Nishimoto; H Ishikawa; J Hata; T Hibi
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

View more
  50 in total

1.  Bupropion Ameliorates Acetic Acid-Induced Colitis in Rat: the Involvement of the TLR4/NF-kB Signaling Pathway.

Authors:  Amir Rashidian; Pegah Dejban; Kiana Karami Fard; Alireza Abdollahi; Mohsen Chamanara; Ahmadreza Dehpour; Amin Hasanvand
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

2.  Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.

Authors:  Qin Qi; Ya-Nan Liu; Xiao-Ming Jin; Lin-Shuang Zhang; Cun Wang; Chun-Hui Bao; Hui-Rong Liu; Huan-Gan Wu; Xiao-Mei Wang
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

3.  In Vitro Models of the Small Intestine: Engineering Challenges and Engineering Solutions.

Authors:  Sarah A Hewes; Reid L Wilson; Mary K Estes; Noah F Shroyer; Sarah E Blutt; K Jane Grande-Allen
Journal:  Tissue Eng Part B Rev       Date:  2020-03-23       Impact factor: 6.389

Review 4.  Human Relevance of Preclinical Studies on the Skeletal Impact of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Swati Rajput; Poonam Mehta; Monika Mittal; Singh Rajender; Naibedya Chattopadhyay
Journal:  Calcif Tissue Int       Date:  2021-02-09       Impact factor: 4.333

5.  Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway.

Authors:  Seyed Mahdi Rezayat; Ahmad-Reza Dehpour; Saeed Mohammadi Motamed; Maryam Yazdanparast; Mohsen Chamanara; Mousa Sahebgharani; Amir Rashidian
Journal:  Inflammopharmacology       Date:  2017-10-24       Impact factor: 4.473

6.  Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran.

Authors:  H Mirjalali; M R Abbasi; N Naderi; Z Hasani; E S Mirsamadi; C R Stensvold; H Balaii; H Asadzadeh Aghdaei; M R Zali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-25       Impact factor: 3.267

7.  Thymol reduces acetic acid-induced inflammatory response through inhibition of NF-kB signaling pathway in rat colon tissue.

Authors:  Mohsen Chamanara; Alireza Abdollahi; Seyed Mahdi Rezayat; Mamoud Ghazi-Khansari; Ahmadreza Dehpour; Ehsan Nassireslami; Amir Rashidian
Journal:  Inflammopharmacology       Date:  2019-03-21       Impact factor: 4.473

Review 8.  Quality of methods reporting in animal models of colitis.

Authors:  Michael Bramhall; Oscar Flórez-Vargas; Robert Stevens; Andy Brass; Sheena Cruickshank
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

9.  Fermented Rice Bran Supplementation Prevents the Development of Intestinal Fibrosis Due to DSS-Induced Inflammation in Mice.

Authors:  Afifah Zahra Agista; Tubagus Bahtiar Rusbana; Jahidul Islam; Yusuke Ohsaki; Halima Sultana; Ryouta Hirakawa; Kouichi Watanabe; Tomonori Nochi; Slamet Budijanto; Suh-Ching Yang; Takuya Koseki; Hisashi Aso; Michio Komai; Hitoshi Shirakawa
Journal:  Nutrients       Date:  2021-05-30       Impact factor: 5.717

10.  Flower extract of Caragana sinica. ameliorates DSS-induced ulcerative colitis by affecting TLR4/NF-κB and TLR4/MAPK signaling pathway in a mouse model.

Authors:  Ting Li; Qiu-Ping Zou; Feng Huang; Gui-Guang Cheng; Ze-Wei Mao; Ting Wang; Fa-Wu Dong; Bao-Jing Li; Hong-Ping He; Yan-Ping Li
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.